Results 221 to 230 of about 3,367,821 (256)

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

Nature Reviews. Cancer, 2007
Ross L. Levine, A. Pardanani, A. Tefferi, D. Gilliland   +3 more
semanticscholar   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi, Katherine A Hutcheson, Gary H Lyman   +2 more
exaly  

Spirituality and religion in oncology

Ca-A Cancer Journal for Clinicians, 2013
John R Peteet
exaly  

Myeloproliferative disorders and the hyperviscosity syndrome.

Hematology/Oncology Clinics of North America, 2010
Bruce D. Adams, R. Baker, J. Lopez, S. Spencer   +3 more
semanticscholar   +1 more source

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2019
Robert A Smith, Stacey A Fedewa
exaly  

Thrombohemorrhagic complications of myeloproliferative disorders.

Blood reviews, 2010
E. Papadakis, R. Hoffman, B. Brenner
semanticscholar   +1 more source

Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
William M Lydiatt, Snehal G Patel, Brian O'Sullivan   +2 more
exaly